What is Twist Bioscience?
Twist Bioscience is a leading synthetic biology company focused on the high-volume, high-precision manufacturing of synthetic DNA. Leveraging a proprietary silicon-based platform, the company empowers researchers across life sciences, medicine, agriculture, and industrial biotechnology to accelerate innovation. Its advanced DNA synthesis capabilities are crucial for applications ranging from fundamental genetic research and drug development to the creation of sustainable industrial solutions, providing reliable, high-quality DNA at an unprecedented scale and speed.
How much funding has Twist Bioscience raised?
Twist Bioscience has raised a total of $728.7M across 14 funding rounds:
Multiple Rounds
$50.2M
Series C
$37M
Series D
$61M
Debt
$20M
Series E
$60M
Share Placement
$50M
Stock Offering
$69M
Stock Offering
$84.1M
Multiple Rounds
$297.4M
Series A (2014): $9.1M with participation from Undisclosed
Grant (2014): $5.1M led by DARPA
Series B (2014): $26M supported by Paladin Capital Group, ARCH Venture Partners, Yuri Milner, and Tao Invest
Debt (2014): $10M featuring Silicon Valley Bank
Series C (2015): $37M backed by Fidelity Management & Research Company, Illumina Inc., Paladin Capital Group, Tao Invest, Foresite Capital Management, ARCH Venture Partners, and Yuri Milner
Series D (2016): $61M with participation from Fidelity Management & Research Company, Paladin Capital Group, WuXi Healthcare Ventures, ARCH Venture Partners, Foresite Capital Management, Cormorant Asset Management, Boris Nikolic, ARCH Overage Fund, Merieux Development, Illumina Inc., Yuri Milner, and Tao Invest
Debt (2016): $20M led by Silicon Valley Bank
Series E (2017): $60M supported by Ditch Plains Capital Management, Reinet Fund, NFT Investment Limited, KANGMEI Group, FIS Global, Biomatics Capital, Bay City Capital, and 3W Partners Capital
Share Placement (2018): $50M featuring Undisclosed
Stock Issuance/Offering (2018): $69M backed by Undisclosed
Stock Issuance/Offering (2019): $84.1M with participation from Undisclosed
Stock Issuance/Offering (2020): $50M led by Undisclosed
Stock Issuance/Offering (2020): $140M supported by Undisclosed
Stock Issuance/Offering (2020): $107.4M featuring Undisclosed
Key Investors in Twist Bioscience
Fidelity Management & Research Company
Fidelity Investments is a financial services company that provides a broad range of investment, wealth management, retirement planning, brokerage, and advisory solutions for individual investors, businesses, employers, and institutions. The company offers access to investment products, financial planning resources, trading platforms, retirement services, and personalized advisory support designed to help clients achieve their long-term financial goals.
Paladin Capital Group
Paladin Capital Group operates as a global multi-stage investment firm specializing in venture capital and growth financing across diverse sectors. The firm deploys capital strategically to identify, support, and scale companies at various stages of development, from early-stage ventures through expansion phases.
ARCH Venture Partners
ARCH Venture Partners is a leading earlystage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
What's next for Twist Bioscience?
With a robust funding history and a recent major strategic investment, Twist Bioscience is well-positioned for continued expansion and technological advancement. The company's focus on scaling its synthetic DNA manufacturing capabilities suggests a strategic push to capture a larger share of the rapidly growing synthetic biology market. Future developments are likely to involve further integration of its platform into diverse research and industrial applications, potentially leading to breakthroughs in areas such as personalized medicine, advanced biofuels, and novel biomaterials. The company's trajectory indicates a strong emphasis on innovation and market leadership within the biotechnology landscape.
See full Twist Bioscience company page
